Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03956784
Other study ID # 69HCL19_0343
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 23, 2020
Est. completion date December 23, 2024

Study information

Verified date May 2024
Source Hospices Civils de Lyon
Contact Arnaud PASQUER, MD
Phone 472.11.69.22
Email arnaud.pasquer@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative management in digestive surgery has been modernized thanks to improved rehabilitation measures. These measures include an earlier refeeding, mobilization, restriction of infusions (out of a total of 22) and showed their benefit in colorectal, gastric and bariatric surgery. It is thus possible to perform sleeve gastrectomy, bypass, restorations of digestive continuity and colectomies with early discharge or one day surgery. The most serious complications (fistula, sepsis) occur in the first 10 days postoperatively with an average readmission rate of 10%. Their screening is based on clinical signs (tachycardia, pain) or biological (C-Reactive Protein (CRP) assay on Day 3 or Day 4). It is important to manage these complications early so that their morbidity is lower, resulting in shorter stays and less severity. The monitoring and safety of patients discharged early are therefore essential and for the moment poorly codified, ranging from simple nursing to follow-up via a health provider. Recently, coordination structures including nurse platform and smartphone follow up app have emerged. Thanks to this system, the patient collects his own history and biological results which allows him to be monitored continuously, as in the hospital. In case of no filling or sign of complication, the nurse platform contacts the patient. This connected follow-up would make it possible to reinforce the safety of the patient discharged early after a complex digestive procedure performed on an outpatient basis. Its benefit has been poorly evaluated but it is however more and more used by surgeons convinced of its interest especially as it goes in the direction of the development of the outpatient activity requested by the High Authority of Health with economic benefits interesting also the administration of the care structures. The purpose of the investigator's study is to evaluate the impact of e-assessed follow-up during 10 days after surgery compared to a conventional follow-up. The hypothesis is that this connected follow-up would allow earlier detection of complications requiring rehospitalization (within 48 hours), resulting in faster and less severe treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 340
Est. completion date December 23, 2024
Est. primary completion date December 23, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient, male or female, age =18 years - Patient hospitalized for colorectal, gastric or bariatric surgery - Patient for whom an outpatient or enhanced recovery after surgery is performed (expected discharge no later than 4 days after surgery) - Patient with a computer, tablet or mobile connected to internet - Patient who agrees to be included in the study and who signs the informed consent form, - Patient affiliated with a healthcare insurance plan. Exclusion Criteria: - Minor patient - Patient who does not understand French, under supervision or guardianship - Mentally unbalanced patients or unable to follow the instructions of a connected follow-up, from the point of view of the investigator - Patient who is unable to give consent

Study Design


Related Conditions & MeSH terms

  • Post-operative Complications After Bariatric Surgery
  • Post-operative Complications After Colorectal Surgery
  • Post-operative Complications After Gastric Surgery
  • Postoperative Complications

Intervention

Device:
E-assessed clinical and biological follow up
Clinical questionnaire: self-evaluation of pain (0 to 10), resumption of transit, bleeding, fever, pulse. In case of no filling, the patient is contacted. An automatic alert system is defined and divide the patient according to three situations: Normal situation Situation requiring the nurse to call back the patient and contact the surgeon if the assessment requires medical advice Disturbing situation requiring contact of the first-line surgeon if a potentially serious event is suspected. Each speaker's place is described for each item in the detailed protocols Biological questionnaire: Biological monitoring (blood count, Ionogram, C-Reactive Protein, urea, creatinine) is performed on D1, D3 and D7. All information is accessible in real time by the surgeon who receives notifications by email and on his smartphone in case of clinical or biological abnormality on patient monitoring.
Other:
Usual at home follow up
An information sheet on the clinical parameters to be monitored will be given to patients and will include the following information: Immediate complications and warning signs: Tachycardia> 120 bpm Dyspnea Rectorragies and / or melena Vomiting with or without presence of blood Major abdominal pain (visual analogue scale> 6/10) Fever> 38 Management to deal with complications: call the service and / or the surgeon Actions to be performed by the patient after the exit:passage of the nurse during 10 days for anticoagulant morning and evening (identical in both study groups) Each patient will be given a prescription to perform a C-Reactive Protein assay on D1, D3 and D7, similarly.

Locations

Country Name City State
France Service de Chirurgie Digestive, Hôpital d'Estaing, CHU de Clermont-Fd Clermont-Ferrand
France Service de Chirurgie Digestive, Hôpital Le Bocage, CHU Dijon Dijon
France Département de Chirurgie Digestive, Hôpital Michallon, CHU Grenoble Grenoble
France Service de Chirurgie Viscérale et Digestive, CH Emile Roux Le Puy en Velay
France Service de Chirurgie Digestive, Hôpital Edouard Herriot, Hospices Civils de Lyon Lyon
France Service de Chirurgie Générale, Digestive et de la Transplantation Hépatique, Hôpital de la Croix Rousse, Hospices Civils de Lyon Lyon
France Service de Chirurgie Digestive, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon Pierre-Bénite
France Service de Chirurgie Digestive et Oncologie Digestive, Hôpital Nord, CHU Saint-Etienne Saint-Étienne

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time required for the management of post-operative complications requiring rehospitalization Number of hours between discharge from hospitalization after digestive surgery and readmission for hospitalization during which medical, surgical, radiological or endoscopic treatment is performed. Within 6 months after surgery
Secondary Severe postoperative complication rate Rate of medical and surgical (> or = grade 3) complications within 30 days after surgery using the Dindo-Clavien classification, described as:
Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications.
Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient.
Within 30 days after surgery
Secondary Early overall complication rate Rate of medical and surgical complications (each grade) within 30 days after surgery using the Dindo-Clavien classification Within 30 days after surgery
Secondary Type of early complications Type (medical or surgical) of late complications (after 30 days) for each procedure according to the Dindo-Clavien classification Within 30 days after surgery
Secondary Severity of early complications Severity of late complications (after 30 days) for each procedure according to the Dindo-Clavien classification Within 30 days after surgery
Secondary Late overall complication rate Rate of medical and surgical complications (each grade) within 6 months after surgery using the Dindo-Clavien classification Within 6 months after surgery
Secondary Type of late complications Type (medical or surgical) of late complications (after 6 months) for each procedure according to the Dindo-Clavien classification Within 6 months after surgery
Secondary Severity of late complications Severity of late complications (after 6 months) for each procedure according to the Dindo-Clavien classification Within 6 months after surgery
Secondary Postoperative mortality Number of patients who died within 30 days and 6 months after surgery Within 30 days and 6 months after surgery
Secondary Readmission of patient Number of patients readmitted within 30 days and 6 months after surgery. Within 30 days and 6 months after surgery
Secondary Quality of life assessed with SF36 questionnaire Before surgery and at 10 and 30 days after surgery, according to the SF36 (Short Form (36) Health Survey) questionnaire.
This questionnaire taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/tiredness, and general health perceptions. It also includes a single item that provides an indication of a perceived change in health.
Before surgery and at 10 and 30 days after surgery
Secondary Quality of life assessed with GIQLI questionnaire Before surgery and at 10 and 30 days after surgery, according to the GIQLI (Gastrointestinal Quality of Life index) questionnaire.
This questionnaire consists of 36 items exploring 5 dimensions or subscales: symptoms, physical condition, emotions, social integration and the effect of any medical treatment. For each item, 5 responses will be proposed to the patients and for each answer, a score ranging from 0 to 4 (highest score = 144) will be assigned. A high score defines a more favorable health state.
Before surgery and at 10 and 30 days after surgery
Secondary Patient satisfaction: VAS Satisfaction will be measured using a visual analog scale, rated from 0 (no satisfaction) to 10 (Perfect Satisfaction) 10 days after surgery
Secondary Patient sense of security Sence of security will be measured using a visual analog scale, rated from 0 (no security felt) to 10 (Complete security felt Satisfaction) 10 days after surgery
Secondary Costs Costs associated with the strategy including the Follow-up care via Mobile App compared to the standard follow-up care strategy. 7 months post-inclusion
Secondary Consequences Consequences associated with the strategy including the Follow-up care via Mobile App compared to the standard follow-up care strategy. 7 months post-inclusion